United Kingdom· GB-APID-375611000001109
Metenix 5mg tablets
A metolazone product containing metolazone, registered in United Kingdom by Sanofi. The same ATC class is registered in 10 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Metolazone is registered in 10 of 19 countries.
Countries holding a registration under ATC C03BA08 (metolazone), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 6 of them publish a price we can compare per daily dose
Metolazone · ATC C03BA08
10 / 19 countries
- Canada
- Denmark
- Finlandprice
- Icelandprice
- Italyprice
- Norwayprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of metolazone costs, country by country.
Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.19 in Italy to $1.25 in Switzerland — a ×6.5 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Metolazone · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.25
- IT Italy$0.19
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Metolazone
- Manufacturer
- Sanofi
- Country
- United Kingdom (GB)
- ATC code
- C03BA08
- ATC class
- Metolazone
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5013487100564
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
326 interactions on record for metolazone.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Metolazone · interactions on record
326 records
- 4 severe
- 208 moderate
- 19 minor
- 91 info
Most severe, free to view
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Aminolevulinic acidL01XD04severe
- Arsenic trioxideL01XX27severe
4 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Metolazone in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMetolazoneIngenus Pharmaceuticals LLC
- NorwayMetolazonAbcur AB (2)
- SwitzerlandMetolazon Galepharm, TablettenGalepharm AG
- IcelandMetolazon AbcurAbcur AB*
- FinlandMetolazon AbcurAbcur AB
- SwedenMetolazon Abcur 5 mg TablettAbcur AB
- ItalyZAROXOLYN*50 cpr 10 mgTEOFARMA Srl
- CanadaZAROXOLYNSANOFI-AVENTIS CANADA INC
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Denmark · Metolazon Abcur
- Finland · Metolazon Abcur
- Iceland · Metolazon Abcur
- Italy · Zaroxolyn
- Norway · Metolazon Abcur
- Portugal · Diulo
- Sweden · Metolazon Abcur
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/acc2c356-a5ae-430f-b4c4-e49fec89a00b GET /v1/drugs/acc2c356-a5ae-430f-b4c4-e49fec89a00b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "375611000001109",
"desc": "Metenix 5mg tablets (Sanofi)",
"form": "Oral tablet",
"vpid": "42213711000001103",
"source": "dmd",
"vtm_id": "776769002",
"strength": "5 mg",
"substance": "Metolazone",
"ingredient": "Metolazone",
"supplier_code": "9190711000001101"
}See everything about metolazone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.